2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q1 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,136,016 | -49.5% | 544,902 | +30.4% | 0.00% | 0.0% |
| Q2 2023 | $4,228,429 | +29.6% | 417,829 | +30.6% | 0.00% | 0.0% |
| Q1 2023 | $3,263,929 | +8.3% | 319,993 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $3,013,195 | -34.2% | 321,579 | +2.2% | 0.00% | -50.0% |
| Q3 2022 | $4,580,000 | +29.1% | 314,711 | +17.1% | 0.00% | +100.0% |
| Q2 2022 | $3,549,000 | +22.3% | 268,817 | +58.0% | 0.00% | 0.0% |
| Q1 2022 | $2,903,000 | -30.9% | 170,131 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $4,204,000 | – | 163,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |